Treating damage to the muscular-skeletal organ system by means of metal implants is set to remain the “gold standard” of muscular-skeletal healing for the foreseeable future. Within the framework of this traditional method of treatment accepted by the market, a paradigm shift from purely metallic to biologically active implants has in recent years taken place in orthopedics. In other words, there has been a move away from simply “repairing” fractures and joint damage to “healing” them.

As a young, fast-growing segment of orthopedics, orthobiology has acquired fundamental significance in the search for new, biological treatment methods. The term “orthobiology” has become a synonym for the inclusion of biology and biochemistry in the development of bone replacement materials for muscular-skeletal healing.

Biomaterials products, or orthobiologicals, include among other things resorbable bone and tissue replacement materials, substances developed in connection with the search for biological substitutes for tissue and organ functions, growth factors, proteins, etc. The possibility of developing an active bone replacement that supports the healing and treatment of damaged bone opens up new prospects for muscular-skeletal healing and is set to revolutionize orthopedics on a long-term basis.

In the field of orthobiology, aap is currently engaged in research into and development of innovative bone replacement materials. Building on sound technological know-how, aap along with its subsidiary aap Biomaterials, which specializes in biomaterials, is also pursuing a strategy of establishing itself as a leading development and production enterprise in the field of tissue engineering. Our ambitious long-term goal is to be market leader in the field of biomaterials.